Back to Search
Start Over
Tivozanib Provides 'Modest' Real-World Benefit in Metastatic RCC
- Source :
- Renal & Urology News. November 21, 2023
- Publication Year :
- 2023
-
Abstract
- Tivozanib conferred a “modest clinical benefit” in a real-world study of patients with metastatic renal cell carcinoma (RCC), according to researchers. The researchers noted that the sequencing of therapies for [...]
Details
- Language :
- English
- ISSN :
- 15509478
- Database :
- Gale General OneFile
- Journal :
- Renal & Urology News
- Publication Type :
- Periodical
- Accession number :
- edsgcl.773570152